Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Too much and not enough: revisiting maintenance rituximab in indolent lymphomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Too much and not enough: revisiting maintenance rituximab in indolent lymphomas.
Too much and not enough: revisiting maintenance rituximab in indolent lymphomas. Haematologica. 2022 02 01; 107(2):353-354.
View in:
PubMed
subject areas
Humans
Lymphoma, Follicular
Lymphoma, Non-Hodgkin
Rituximab
authors with profiles
Sonali Smith